Earnings Call · Q3 FY2023·2023-10-26

Q3 23EPS -17.08%·Rev n/aQ2 23EPS +11.94%·Rev n/aQ1 23EPS -4.02%·Rev n/aQ4 22EPS -3.78%·Rev n/a⚠ consensus missing

BIO-RAD LABORATORIES, INC. BIO

Edward Chung — Investor Relations or Communications Officer

Andy Last — Unspecified senior executive, likely President or head of Life Sciences division

Ilan Daskal — Executive Vice President and Chief Financial Officer

Norman Schwartz — Chief Executive Officer

−7.2%1d on move date−6.7% vs SPY3d−5.6%5d−3.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BIO calls or request research access.

More BIO calls Browse calls Request research access